Summary
Smartphone applications (“apps”) with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers’ claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Ferrante di Ruffano, L., Takwoingi, Y., Dinnes, J., Chuchu, N., Bayliss, S.E., Davenport, C. et al. Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults. Cochrane Database Syst. Rev. 12, CD013186 (2019).
Ipsos-MORI. Technology tracker Q3. https://www.ipsos.com/sites/default/files/ct/publication/documents/2018-10/techtracker_q3_2018_final2.pdf (2018).
Flaten, H. K., St Claire, C., Schlager, E., Dunnick, C. A. & Dellavalle R. P. Growth of mobile applications in dermatology—2017 update. Dermatol Online J. 24, 13030/qt3hs7n9z6 (2018)
Freeman, K., Dinnes, J., Chuchu, N., Takwoingi, Y., Bayliss, S.E., Matin, R.N. et al. Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studies. BMJ 368, m127 (2020).
Udrea, A., Mitra, G.D., Costea, D., Noels, E.C., Wakkee, M., Siegel, D.M. et al. Accuracy of a smartphone application for triage of skin lesions based on machine learning algorithms. J. Eur. Acad. Dermatol. Venereol. 34, 648–655 (2020).
Deeks, J. J., Dinnes, J. & Williams, H. C. Sensitivity and specificity of SkinVision are likely to have been overestimated. J. Eur. Acad. Dermatol. Venereol. 34, e582–e583 (2020).
Cancer Research UK. Non-melanoma skin cancer incidence statistics (2016).
FDA. Mobile medical applications—guidance for industry and food and drug administration staff (Food and Drug Administration, Rockville MD, 2015).
Singh, K., Drouin, K., Newmark, L.P., Lee, J., Faxvaag, A., Rozenblum, R. et al. Many mobile health apps target high-need, high-cost populations, but gaps remain. Health Aff. (Millwood) 35, 2310–2318 (2016).
Torous, J. B., Chan, S.R., Gipson, S.Y.M.T., Kim, J.W., Nguyen, T.Q., Luo, J. et al. A hierarchical framework for evaluation and informed decision making regarding smartphone apps for clinical care. Psychiatr. Serv. 69, 498–500 (2018).
Acknowledgements
We would like to thank Prof. Jonathan Deeks and Prof. Hywel Williams for comments on an earlier version of the manuscript.
Author information
Authors and Affiliations
Contributions
R.M. and J.D. contributed equally to this work. Both authors contributed to the conception of the work, drafted the manuscript and approved the final version. The corresponding author attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent to publish
Not applicable.
Data availability
Not applicable.
Competing interests
The authors declare no competing interests.
Funding information
J.D. is supported by the National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham (grant reference No BRC-1215-20009). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Matin, R.N., Dinnes, J. AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation. Br J Cancer 124, 1749–1750 (2021). https://doi.org/10.1038/s41416-021-01302-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-021-01302-3
This article is cited by
-
Artificial intelligence in skin cancer smartphone applications
Die Dermatologie (2024)
-
Digitalisierung in der Dermatoonkologie: künstliche Intelligenz zur Diagnostik
best practice onkologie (2023)